tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
CTMX is currently covered by 9 analysts with an average price target of $7.79. This is a potential upside of $3.36 (75.85%) from yesterday's end of day stock price of $4.43.
CytomX Therapeutics's activity chart (see below) currently has 50 price targets and 53 ratings on display. The stock rating distribution of CTMX is 38.1% BUY, 52.38% HOLD and 9.52% SELL.
Analysts average stock forecasts to be materialized ratio is 30.48% with an average time for these price targets to be met of 112.71 days.
Highest price target for CTMX is $3.25, Lowest price target is $3, average price target is $7.79.
Most recent stock forecast was given by ETZER DAROUT from BMO on 01-May-2024.
Currently out of the existing stock ratings of CTMX, 8 are a BUY (38.1%), 11 are a HOLD (52.38%), 2 are a SELL (9.52%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
3.25
$-1.18 (-26.64%)
3.3
5 days ago
6/10 (60%)
$-1.88 (-36.65%)
334
Sell
14 days ago
0/2 (0%)
$7.4 (160.87%)
Buy
3
$-1.43 (-32.28%)
2
5 months 28 days ago
4/8 (50%)
$1.75 (140.00%)
133
Hold
2
$-2.43 (-54.85%)
4
1 years 1 months 8 days ago
2/6 (33.33%)
$0.48 (31.58%)
500
Hold
1.75
$-2.68 (-60.50%)
1.5
1 years 9 months 1 days ago
2/5 (40%)
$0.09 (5.42%)
59
What is CTMX (CytomX Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on CTMX (CytomX Therapeutics) with a proven track record?
Which analyst has the most public recommendations on CTMX (CytomX Therapeutics)?
Which analyst is the currently most bullish on CTMX (CytomX Therapeutics)?
Which analyst is the currently most reserved on CTMX (CytomX Therapeutics)?
